Home
Sessions
Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology
Phase II Randomized Trial of Low-Dose Radiation Therapy plus Donanemab in Early Alzheimer's Disease: A Radiation-as-a-Drug Approach (RAD-CLEAR)

Sep 28

PQA 04 - Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology

2896 - Phase II Randomized Trial of Low-Dose Radiation Therapy plus Donanemab in Early Alzheimer's Disease: A Radiation-as-a-Drug Approach (RAD-CLEAR)

03:00pm - 04:00pm ET

Poster Hall - Exhibit Hall A

Presenter(s)

Evan Thomas, MD, PhD - Renaissance Institute for Precision Oncology & Radiosurgery , Winter Park , FL